Evidence map›Paper›PMID 35189628›Full record

ArticleFrontiers in pharmacology2022

Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis.

Yingqi She, Qinfeng Huang, Zhen Ye, Yu Hu, Mingquan Wu, Kaihua Qin, Ailing Wei, Xin Yang, Yuyao Liu, Cuihan Zhang and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yingqi SheSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Qinfeng HuangDepartment of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China.
Zhen YeSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yu HuSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Mingquan WuDepartment of Pharmacy, Sichuan Provincial Orthopedic Hospital, Chengdu, China.
Kaihua QinHealth Preservation and Rehabilitation College, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ailing WeiDepartment of Liver Disease, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China.
Xin YangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yuyao LiuPharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Cuihan ZhangPharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Qiaobo YeSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar2021.714287.].

Indexed as

Chinese medicinal formulasdrastic medicinalsmeta-analysisprimary liver cancertherapeutic principletranscatheter arterial chemoembolization

Identifiers

PMID35189628
PMCPMC8855032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.